Forty Seven Inc. to Host Key Opinion Leader Breakfast Symposium on FSI-174, anti-cKIT Antibody, on January 22, 2019
Guest speakers scheduled to present at the event include:
Irv Weissman, M.D., Co-Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicineand Director of the Stanford Ludwig Center for Cancer Stem Cell Research
- Maria Grazia Roncarolo, M.D., Co-Director of the
Stanford Institute for Stem Cell Biology and Regenerative Medicine; George D. Smith Professor in Stem Cell and Regenerative Medicine at Stanford University; Chief, Division of Pediatric Stem Cell Transplantation and Regenerative Medicineat Stanford University; and Co-Director, Bass Center for Childhood Cancer and Blood Diseases
Additionally, Forty Seven management will provide an overview of its initial development strategy for FSI-174. The Company plans to present initial preclinical data for FSI-174 in the first half of 2019, and to complete investigational new drug application-enabling studies in 2019.
A live webcast of the presentation will be available under “Events & Presentations” in the Investors section of the Company’s website at www.fortyseveninc.com. A replay of the webcast will be available on the Forty Seven website for 90 days following the event.
For journalist enquiries please contact
For investor enquiries please contact
Source: Forty Seven, Inc.